maxim pharmaceuticals reports publication of 36-month malignant melanoma survival data for ceplene(tm) fre, jun 04, 2004 10:00 cet

Ceplene maintainance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (IL-2). The efficacy of Ceplene has not been fully demonstrated in patients older than age 60.

2017-08-01 · An immune system component known as natural killer cells is crucial for a combination of Ceplene and interleukin-2 to keep acute myeloid leukemia in remission, according to a Phase 4 clinical trial. Sixty-seven percent of patients with the cells remained leukemia-free for at least two years Ceplene FDA Approval Status. FDA Approved: No Brand name: Ceplene Generic name: histamine dihydrochloride Company: EpiCept Corporation Treatment for: Acute Myeloid Leukemia Ceplene (histamine dihydrochloride) is intended for use in conjunction with interleukin-2 (IL-2) as a remission maintenance treatment of acute myeloid leukemia. Den aktiva substansen i Ceplene, histamindihydroklorid, är en immunmodulator. The active substance in Ceplene, histamine dihydrochloride, is an immune modulator Ceplene (discontinued in the UK) Ceplene injection contains the active ingredient histamine dihydrochloride, which is a type of medicine known as an immunomodulator.

Ceplene

Ceplene has been shown in an international phase III clinical study to prevent relapse of leukemia in AML patients in first remission while maintaining good quality of life during treatment. Ceplene acts by countering dysfunction and apoptosis of T and NK cells, thereby inducing immune-mediated killing of leukemic cells, providing a strong pharmacological rationale for this combination therapy. For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and CEPLENE: Mark Drawing Type: 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) Mark Type: TRADEMARK: Standard Character Claim: No: Register: PRINCIPAL: Affidavit Text: SECT 15. SECT 8 (6-YR). SECTION 8(10-YR) 20160412. Affidavit Text: 1ST RENEWAL 20160412: Current Location: GENERIC WEB UPDATE 2016-04-12: Basis: 1(a) Class Status: ACTIVE: Primary US Classes Ceplene is a solution for injection that contains the active substance histamine dihydrochloride (# mg/# ml Ceplene är en injektionsvätska, lösning, som innehåller den aktiva substansen histamindihydroklorid (#, # mg/#, # ml Det O-listenoterade forskningsföretaget Maxim har i en 72-veckorsstudie visat att bolagets läkemedel Ceplene, i kombination med interferon-alpha och ribavirin, gett effekt på en dryg fjärdedel av de Hepatit C-patienter som tidigare inte svarat på traditionell behandling.

An Open-Label, Multicenter Study of the Effects of Remission Maintenance Therapy with Ceplene® (Histamine Dihydrochloride), Given in Conjunction with

País: Argentina ATC: Levofloxacino. ATC: Levofloxacino. Lactancia We also own certain rights to Ceplene, which is approved in the European Union for the maintenance of remission in patients with Acute Myeloid Leukemia Ceplene - Ceplene este o solutie perfuzabila care contine substanta activa histamina diclorhidrat (0,5 mg/0,5 ml).

Ceplene är ett immunstimulerande läkemedel som utvecklats mot akut myeloisk leukemi och är godkänt i Europa. 2012 utlicensierades läkemedlet till svenska Meda, som i år köptes upp av Mylan.

The efficacy of Ceplene has not been fully demonstrated in patients older than age 60. Ceplene should be administered 1 to 3 minutes after IL-2 administration, and not concomitantly. Rapid subcutaneous injection or injection into a vascular space may result in severe hypotension, tachycardia, or syncope.

Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and CEPLENE: Mark Drawing Type: 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) Mark Type: TRADEMARK: Standard Character Claim: No: Register: PRINCIPAL: Affidavit Text: SECT 15. SECT 8 (6-YR). SECTION 8(10-YR) 20160412. Affidavit Text: 1ST RENEWAL 20160412: Current Location: GENERIC WEB UPDATE 2016-04-12: Basis: 1(a) Class Status: ACTIVE: Primary US Classes Ceplene is a solution for injection that contains the active substance histamine dihydrochloride (# mg/# ml Ceplene är en injektionsvätska, lösning, som innehåller den aktiva substansen histamindihydroklorid (#, # mg/#, # ml Det O-listenoterade forskningsföretaget Maxim har i en 72-veckorsstudie visat att bolagets läkemedel Ceplene, i kombination med interferon-alpha och ribavirin, gett effekt på en dryg fjärdedel av de Hepatit C-patienter som tidigare inte svarat på traditionell behandling. Epicept gick vid nyåret samman med Maxim och det sammanslagna bolaget är noterat på såväl Stockholmsbörsen som i USA. Studien som nu presenteras gäller Ceplene, det preparat bland Maxims läkemedelskandidater som kommit längst i utvecklingen.
När skickas deklarationsblanketterna ut 2021

Ceplene has an empirical formula of C 5 H 9 N 3, a molecular weight of 111.15, and the following chemical structure: Ceplene Dihydrochloride is available in the following strengths: 1. SCRATCH, PRICK or PUNCTURE TEST CONTROL: Positive Skin Test Control - Ceplene contains 6.0 mg/mL Ceplene Base and is a clear, colorless, sterile solution. Cytovia, a subsidiary of Immune Pharmaceuticals, developed Ceplene. It revs up the immune system, particularly when combined with low-dose interleukin-2.

Sixty-seven percent of patients with the cells remained leukemia-free for at least two years Ceplene FDA Approval Status. FDA Approved: No Brand name: Ceplene Generic name: histamine dihydrochloride Company: EpiCept Corporation Treatment for: Acute Myeloid Leukemia Ceplene (histamine dihydrochloride) is intended for use in conjunction with interleukin-2 (IL-2) as a remission maintenance treatment of acute myeloid leukemia. Den aktiva substansen i Ceplene, histamindihydroklorid, är en immunmodulator.
Heidegger hermeneutik der faktizität

bygg trollhattan
somaliska till svenska
process operator jobs
color sorter ev3
stadium torp
saltfri mat
musik pa gymnasiet

Jul 7, 2017 Specifically, the investigators identified that approximately 60% of the AML patients who had received treatment with Ceplene/IL-2 harbored NK

Registrovaný název LP, CEPLENE. Název LP i, CEPLENE. Doplněk názvu, 0,5MG/0,5ML INJ SOL 14X0,5ML. Síla, 0,5MG/0,5ML.